Copyright Reports & Markets. All rights reserved.

Global Transdermal Drug Delivery Systems Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Fentanyl
    • 1.2.3 Nitroglycerin
    • 1.2.4 Estradiol
    • 1.2.5 Nicotine
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 OTC
    • 1.3.3 Rx
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Transdermal Drug Delivery Systems Market Perspective (2016-2027)
  • 2.2 Transdermal Drug Delivery Systems Growth Trends by Regions
    • 2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2016-2021)
    • 2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
  • 2.3 Transdermal Drug Delivery Systems Industry Dynamic
    • 2.3.1 Transdermal Drug Delivery Systems Market Trends
    • 2.3.2 Transdermal Drug Delivery Systems Market Drivers
    • 2.3.3 Transdermal Drug Delivery Systems Market Challenges
    • 2.3.4 Transdermal Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
    • 3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2016-2021)
    • 3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2016-2021)
  • 3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
  • 3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
    • 3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2020
  • 3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
  • 3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
  • 3.7 Date of Enter into Transdermal Drug Delivery Systems Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Transdermal Drug Delivery Systems Breakdown Data by Type

  • 4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2016-2021)
  • 4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2022-2027)

5 Transdermal Drug Delivery Systems Breakdown Data by Application

  • 5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2016-2021)
  • 5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Transdermal Drug Delivery Systems Market Size (2016-2027)
  • 6.2 North America Transdermal Drug Delivery Systems Market Size by Type
    • 6.2.1 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
    • 6.2.2 North America Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
    • 6.2.3 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
  • 6.3 North America Transdermal Drug Delivery Systems Market Size by Application
    • 6.3.1 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
    • 6.3.2 North America Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
    • 6.3.3 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
  • 6.4 North America Transdermal Drug Delivery Systems Market Size by Country
    • 6.4.1 North America Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
    • 6.4.2 North America Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Transdermal Drug Delivery Systems Market Size (2016-2027)
  • 7.2 Europe Transdermal Drug Delivery Systems Market Size by Type
    • 7.2.1 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
    • 7.2.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
    • 7.2.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
  • 7.3 Europe Transdermal Drug Delivery Systems Market Size by Application
    • 7.3.1 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
    • 7.3.2 Europe Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
    • 7.3.3 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
  • 7.4 Europe Transdermal Drug Delivery Systems Market Size by Country
    • 7.4.1 Europe Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
    • 7.4.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2016-2027)
  • 8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type
    • 8.2.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application
    • 8.3.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region
    • 8.4.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Transdermal Drug Delivery Systems Market Size (2016-2027)
  • 9.2 Latin America Transdermal Drug Delivery Systems Market Size by Type
    • 9.2.1 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
    • 9.2.2 Latin America Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
    • 9.2.3 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
  • 9.3 Latin America Transdermal Drug Delivery Systems Market Size by Application
    • 9.3.1 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
    • 9.3.2 Latin America Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
    • 9.3.3 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
  • 9.4 Latin America Transdermal Drug Delivery Systems Market Size by Country
    • 9.4.1 Latin America Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
    • 9.4.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2016-2027)
  • 10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type
    • 10.2.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application
    • 10.3.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country
    • 10.4.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Hisamitsu
    • 11.1.1 Hisamitsu Company Details
    • 11.1.2 Hisamitsu Business Overview
    • 11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
    • 11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.1.5 Hisamitsu Recent Development
  • 11.2 Mylan
    • 11.2.1 Mylan Company Details
    • 11.2.2 Mylan Business Overview
    • 11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
    • 11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.2.5 Mylan Recent Development
  • 11.3 GSK
    • 11.3.1 GSK Company Details
    • 11.3.2 GSK Business Overview
    • 11.3.3 GSK Transdermal Drug Delivery Systems Introduction
    • 11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.3.5 GSK Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Company Details
    • 11.4.2 Novartis Business Overview
    • 11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
    • 11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.4.5 Novartis Recent Development
  • 11.5 Teve (Actavis)
    • 11.5.1 Teve (Actavis) Company Details
    • 11.5.2 Teve (Actavis) Business Overview
    • 11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
    • 11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.5.5 Teve (Actavis) Recent Development
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Company Details
    • 11.6.2 Johnson & Johnson Business Overview
    • 11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
    • 11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.6.5 Johnson & Johnson Recent Development
  • 11.7 Lohmann
    • 11.7.1 Lohmann Company Details
    • 11.7.2 Lohmann Business Overview
    • 11.7.3 Lohmann Transdermal Drug Delivery Systems Introduction
    • 11.7.4 Lohmann Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.7.5 Lohmann Recent Development
  • 11.8 Teikoku Seiyaku
    • 11.8.1 Teikoku Seiyaku Company Details
    • 11.8.2 Teikoku Seiyaku Business Overview
    • 11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
    • 11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.8.5 Teikoku Seiyaku Recent Development
  • 11.9 Bayer
    • 11.9.1 Bayer Company Details
    • 11.9.2 Bayer Business Overview
    • 11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
    • 11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.9.5 Bayer Recent Development
  • 11.10 Novartis
    • 11.10.1 Novartis Company Details
    • 11.10.2 Novartis Business Overview
    • 11.10.3 Novartis Transdermal Drug Delivery Systems Introduction
    • 11.10.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.10.5 Novartis Recent Development
  • 11.11 Teve (Actavis)
    • 11.11.1 Teve (Actavis) Company Details
    • 11.11.2 Teve (Actavis) Business Overview
    • 11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
    • 11.11.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.11.5 Teve (Actavis) Recent Development
  • 11.12 Qizheng
    • 11.12.1 Qizheng Company Details
    • 11.12.2 Qizheng Business Overview
    • 11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
    • 11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.12.5 Qizheng Recent Development
  • 11.13 Endo
    • 11.13.1 Endo Company Details
    • 11.13.2 Endo Business Overview
    • 11.13.3 Endo Transdermal Drug Delivery Systems Introduction
    • 11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.13.5 Endo Recent Development
  • 11.14 Huarun 999
    • 11.14.1 Huarun 999 Company Details
    • 11.14.2 Huarun 999 Business Overview
    • 11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
    • 11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.14.5 Huarun 999 Recent Development
  • 11.15 Haw Par
    • 11.15.1 Haw Par Company Details
    • 11.15.2 Haw Par Business Overview
    • 11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
    • 11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.15.5 Haw Par Recent Development
  • 11.16 Nichiban
    • 11.16.1 Nichiban Company Details
    • 11.16.2 Nichiban Business Overview
    • 11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
    • 11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.16.5 Nichiban Recent Development
  • 11.17 Mentholatum
    • 11.17.1 Mentholatum Company Details
    • 11.17.2 Mentholatum Business Overview
    • 11.17.3 Mentholatum Transdermal Drug Delivery Systems Introduction
    • 11.17.4 Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.17.5 Mentholatum Recent Development
  • 11.18 Laboratoires Genevrier
    • 11.18.1 Laboratoires Genevrier Company Details
    • 11.18.2 Laboratoires Genevrier Business Overview
    • 11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
    • 11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2016-2021)
    • 11.18.5 Laboratoires Genevrier Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Transdermal Drug Delivery Systems Scope and Market Size
    Transdermal Drug Delivery Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Other

    Segment by Application
    OTC
    Rx

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Novartis
    Teve (Actavis)
    Qizheng
    Endo
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum
    Laboratoires Genevrier

    Buy now